Knowledge Center
Rely on the thought leader in clinical diabetes research.
Rely on the thought leader in clinical diabetes research.
Profil is more than a CRO. As a global leader in clinical diabetes research, we have amassed a vast pool of knowledge about this disease and associated treatments. We are just as dedicated to disseminating this knowledge as we are to ensuring optimal, state-of-the-art trial and study design.
Let us share our experiences with you. To see the latest thinking on diabetes and obesity research, browse through our scientific publications or our Profil Blog. Then, discover more about our methods and technology in our past and current online seminars.
We have published with the following sponsors:
 ISO 13485:2016
|
 ISO 9001:2015
|
Andersen, G. et al. 2021. ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Diabetes Obes Metab. 2021 Apr;23(4):961-970.
